account_balance
Investment manager · 13F filer · SEC CIK 1910264
SR One Capital Management, LP
Reported value$1.04Bas of Jun 30, 2026
Positions15 3 new, 2 sold out
Top 10 weight95%MANE alone is 28%
FiledAug 1243 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
MANE
Veradermics, Inc.
28.4%
ZBIO
Zenas BioPharma, Inc
12.3%
CRSP
CRISPR Therapeutics AG
10.7%
AVLN
Avalyn Pharma, Inc
10.5%New
DSGN
Design Therapeutics, Inc.
9.1%
ODTX
Odyssey Therapeutics, Inc.
6.8%New
ALMS
Alumis Inc.
5.3%
ORIC
ORIC Pharmaceuticals, Inc.
4.8%Added
MLYS
Mineralys Therapeutics Inc.
4.1%
SPRY
ARS Pharmaceuticals, Inc.
3.1%
5 others
4.9%
Box size is the share of the fund's reported holdings. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed